Crossmark

Exploration of the role of emotional expression of treatment-resistant schizophrenia patients having followed virtual reality therapy: a content analysis

Crossref DOI link: https://doi.org/10.1186/s12888-023-04861-2

Published Online: 2023-06-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hudon, Alexandre

Lammatteo, Veronica

Rodrigues-Coutlée, Sophie

Dellazizzo, Laura

Giguère, Sabrina

Phraxayavong, Kingsada

Potvin, Stéphane

Dumais, Alexandre
Funding

Funding for this research was provided by:

Institut de Valorisation des Données

Fonds de Recherche du Québec - Santé

Chaire Eli Lilly Canada de recherche en schizophrénie

Canada First Research Excellence Fund

Otsuka Canada Pharmaceutical
License Information

Text and Data Mining valid from 2023-06-12

Version of Record valid from 2023-06-12
More Information

Article History

Received: 29 January 2023

Accepted: 10 May 2023

First Online: 12 June 2023

Declarations

:

: The authors declare that they have no competing interests.

: This study was approved by the institutional ethical committee. Patients that are part of this study were selected based on the proof-of-concept trial from Percy du Sert 2018 ‘s study and Dellazizzo 2021s study [CitationRef removed, CitationRef removed]. The trial was conducted in accordance with the Declaration of Helsinki and was approved by the institutional ethical committee (CER IPPM 16-17-06). The study has been approved by the ethics committee of CR-IUSMM. We obtained written informed consent from all patients.

: Not applicable.

Document is current

Any future updates will be listed below